Fibrocell to Present at 21st Annual BIO CEO & Investor Conference
February 06, 2019 08:00 ET
|
Fibrocell Science Inc.
EXTON, Pa., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective...
Inovalon Announces Fourth Quarter and Full Year 2018 Earnings Conference Call
February 06, 2019 07:55 ET
|
Inovalon Holdings, Inc.
BOWIE, Md., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that...
Elixinol Global Significantly Expands European Operations
February 05, 2019 13:55 ET
|
Elixinol LLC
DENVER, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Elixinol, a wholly owned subsidiary of Elixinol Global (referred hereafter as EXL) (ASX: EXL; OTCQX: ELLXF), has expanded its EU operations with key...
HealthLynked Announces New Mobile Technology to Onboard Patients at Healthcare Provider Locations
February 05, 2019 08:00 ET
|
HealthLynked Corp
NAPLES, Fla., Feb. 05, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) (the “Company”), a leading digital healthcare business, announced today that it has released new technology to onboard...
BioSig Appoints John Kowalski to Lead Commercialization of PURE EP
February 05, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Feb. 05, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
Emerald Health Therapeutics Secures Proprietary Extraction Technology and Extraction Capabilities in Agreement with Indena
February 05, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
Emerald receives certain exclusive rights to established Phytosome® technology to enhance absorption and bioavailability of cannabinoid products Leading global extraction researcher and manufacturer...
American Premium Water Corp. (HIPH) Scores a Touchdown with Participation in Super Bowl LIII Week Festivities
February 04, 2019 10:30 ET
|
American Premium Water Corporation
PLAYA VISTA, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- American Premium Water Corporation (OTC: HIPH) announces the successful participation in events and parties leading up to Super Bowl LIII in...
CytoDyn Announces Productive Conference Call with FDA Regarding First BLA Submission for Leronlimab (PRO 140) Combination Therapy at 700 mg Dose
February 01, 2019 06:00 ET
|
CytoDyn Inc.
Successful interim results in the 700 mg monotherapy arm prompted the FDA to allow CytoDyn to switch all remaining combination therapy patients from CD02-Extension study from 350 mg to 700 mg dose ...
Ford Government Health Care Report Not a Prescription for a Cure: Coalition Takes Serious Issue with Devlin's Claims
January 31, 2019 10:49 ET
|
Ontario Health Coalition
TORONTO, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Rueben Devlin's report was released today with the central communications headline from the Ford government that more hospital beds will not solve hallway...
Advancements in the Treatment of Myelodysplastic Syndromes and RAS-Mutated Lung Cancers to be Presented by Key Opinion Leaders on Thursday, February 7, 2019, in New York City
January 31, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
Invitation-only breakfast event sponsored by Onconova Therapeutics will also be webcast, beginning at 8:00 a.m. EST NEWTOWN, Pa., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc....